Arca Biopharma | ABIO - Bienes





Bienes Cambio Fecha
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 96.05B 409M 2026-09
Arca Biopharma USD 1.23B 91.63M 2026-09
Biogen USD 32.05B 32.5M 2026-09
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Capricor Therapeutics USD 330.37M 38.37M 2026-09
Cipla INR 434.34B 9.38B 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.82B 99.77M 2026-09
Daiichi Sankyo JPY 4.26T 144.08B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Grifols EUR 23.15B 142.7M 2025-12
Laboratory Of America USD 18.92B 392.3M 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
Otsuka Holdings JPY 4.32T 72.62B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
United Therapeutics USD 7.03B 186M 2026-09